Stockscreener 앱 받기
0.392
5.95%
0.022
Athira Pharma Inc 주식(ATHA)의 최신 뉴스
Can momentum traders help lift Athira Pharma Inc.Free Risk-Adjusted Picks With Exit Strategy - Newser
Will Athira Pharma Inc. rebound enough to break evenPortfolio Positioning Strategy With Timing - Newser
Athira Pharma Inc. stock prediction for this weekAI Screener Based Stock Summary Report - Newser
Can machine learning forecast Athira Pharma Inc. recoveryInstitutional Holding Behavior Pattern Analysis - Newser
What to do if you’re stuck in Athira Pharma Inc.Free Stock Selection With High Accuracy - Newser
Reversal indicators forming on Athira Pharma Inc. stockWeekly Trend Watch with Market Signals - Newser
How to monitor Athira Pharma Inc. with trend dashboardsSmart Safety Strategy With Real Data Analysis - Newser
Using R and stats models for Athira Pharma Inc. forecastingFree Low Risk High Return Opportunities - Newser
Using fundamentals and technicals on Athira Pharma Inc.Low Risk Strategy with Smart Entry Zones - Newser
Is Athira Pharma Inc. building a consolidation baseFree Weekly Setup With 3x Return Potential - Newser
Why Athira Pharma Inc. stock attracts strong analyst attentionFast-Growing Stock Candidates - sisain.net
Analyzing Athira Pharma Inc. with risk reward ratio chartsROI Focused Setup Screener With Exit Markers - Newser
Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Athira (ATHA) Q2 Loss Narrows 74% - The Motley Fool
Athira Pharma Q2 net loss narrows - TradingView
Athira's New ALS Drug ATH-1105 Achieves Critical Safety Milestone in Phase 1 Trial, Strategic Review Continues - Stock Titan
Competitive Positioning of Athira Pharma Inc.: Is It Leading or LaggingEntry Opportunity Screener with Confirmation - Newser
Can technical indicators confirm Athira Pharma Inc.’s reversalWeekly Stock Market Strategy Summary - Newser
Athira Pharma (ATHA) to Release Earnings on Thursday - Defense World
How Athira Pharma Inc. stock performs during market volatilityAI Model Forecasting Reversal and Breakout Zones - Newser
Is Athira Pharma Inc. a growth stock or a value stockOver 200% growth - Jammu Links News
Should I hold or sell Athira Pharma Inc. stock in 2025Explosive returns - Jammu Links News
What are analysts’ price targets for Athira Pharma Inc. in the next 12 monthsAchieve rapid returns with smart investment plans - Jammu Links News
Athira Pharma Inc. Stock Analysis and ForecastCapitalize on momentum-driven opportunities - Jammu Links News
What markets is PYPD expanding into Is Athira Pharma Inc. stock a good long term investment optionAchieve breakthrough profits with smart strategies - Jammu Links News
What makes Athira Pharma Inc. stock price move sharplyUnlock steady growth with low-risk stocks - Jammu Links News
Will Athira Pharma Inc. bounce back from current supportTechnical Chart Summary for Momentum Stocks - Newser
Does Athira Pharma Inc. stock perform well during market downturnsCapitalize on fast-moving stock trends - Jammu Links News
What is Athira Pharma Inc. company’s growth strategyExceptional ROI - Jammu Links News
What are the latest earnings results for Athira Pharma Inc.Discover stocks with massive upside potential - Jammu Links News
What institutional investors are buying Athira Pharma Inc. stockGet expert analysis on top stock picks - Jammu Links News
Why is Athira Pharma Inc. stock attracting strong analyst attentionUnlock powerful market insights for success - Jammu Links News
Is it the right time to buy Athira Pharma Inc. stockInvest like a pro with expert recommendations - jammulinksnews.com
How volatile is Athira Pharma Inc. stock compared to the marketMaximize returns with disciplined trading - Jammu Links News
New Product Launches: Will They Boost Athira Pharma Inc. Stock in 2025Daily Trade Setup Forecast with Confidence - Newser
0.24%
3.39%
자본화:
|
볼륨(24시간):